Placeholder Banner

BIO Letter to White House on Need for Animal Biotech Reform in Wake of COVID-19

April 7, 2020

As part of the Administration’s comprehensive response to the unprecedented health and economic impacts from the COVID-19 pandemic, the Biotechnology Innovation Organization (BIO) respectfully requests that the U.S. government immediately reform its approach to oversight of animals with intentional genomic alterations. We are calling on the White House to direct the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop and execute a memorandum of understanding (MOU) clarifying regulatory responsibilities over these animals within 30 days.

Download Full Comments Below
BIO Greenwood Letter to President Trump on Animal Biotech
Discover More
We write to you in strong support of President Biden’s nomination of Jewel Bronaugh, PhD to serve as Deputy Secretary of Agriculture and ask that you quickly approve her nomination. As leaders of the nation’s food and agricultural organizations, we…
The Biotechnology Innovation Organization (BIO) is pleased to submit a statement for the record to the United States House of Representatives Committee on Energy and Commerce Subcommittee on Environment and Climate Change hearing entitled, "The…
The Biotechnology Innovation Organization (BIO) welcomes the United Kingdom’s (UK) consultation on the application of genome editing in the breeding of plants and animals.  The UK has the unique opportunity to be the first country within Europe…